Zoetis Stock
StockStockPrice
Historical dividends and forecast
Zoetis has so far distributed $1.296 in 2024. The next dividend will be paid on 03.12.2024
CHART BY
Frequently asked questions
What is Zoetis's market capitalization?
What is Zoetis's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Zoetis?
What are the analyst ratings and target price for Zoetis's stock?
What is Zoetis's revenue over the trailing twelve months?
Is Zoetis paying dividends?
What is the EBITDA for Zoetis?
What is the free cash flow of Zoetis?
What is the 5-year beta of Zoetis's stock?
How many employees does Zoetis have, and what sector and industry does it belong to?
What is the free float of Zoetis's shares?
Financials
Market Cap
$78.48B5Y beta
0.89EPS (TTM)
$5.319Free Float
450.25MP/E ratio (TTM)
32.71Revenue (TTM)
$9.15BEBITDA (TTM)
$3.84BFree Cashflow (TTM)
$1.54BPricing
Analyst Ratings
The price target is $211.69 and the stock is covered by 16 analysts.
Buy
15
Hold
1
Sell
0
Information
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
14,100
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker